Alerts & Updates 16th Jul 2024
On July 3, 2024, the Central Drugs Standard Control Organisation (CDSCO) issued a guidance document outlining the new procedures for obtaining export NOCs, including stringent documentation requirements and quality control measures. This regulatory development comes in lieu of measures India has been undertaking to enhance drug safety and quality of its drug exports by centralizing the issuance of “No Objection Certificates” (NOCs) for exporting unapproved, banned, or new drugs. It aims to restore confidence in Indian pharmaceuticals by ensuring stringent regulatory oversight.
As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.